We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
State Street SPDR S&P Retail ETF
XRT
$654M
| $5.54M | 0.01% |
+86,888
| New | +$5.33M |
|
952
Intuit
INTU
$89B
| $5.54M | 0.01% |
12,087
-71,118
| -85% | -$31.1M |
|
953
Enel Chile
ENIC
$6.28B
| $5.53M | 0.01% |
1,662,089
+865,311
| +109% | +$2.55M |
|
|
NFYS
954
DELISTED
Enphys Acquisition Corp.
NFYS
| $5.53M | 0.01% |
532,464
| – | – |
|
955
Rexford Industrial Realty
REXR
$8.19B
| $5.52M | 0.01% |
+105,784
| New | +$5.77M |
|
956
CNA Financial
CNA
$14.1B
| $5.51M | 0.01% |
142,614
+39,249
| +38% | +$1.53M |
|
957
Huntington Bancshares
HBAN
$35.5B
| $5.49M | 0.01% |
509,365
-556,930
| -52% | -$5.95M |
|
958
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
| $5.48M | 0.01% |
41,300
-132,900
| -76% | -$17.5M |
|
959
Petrobras
PBR
$116B
| $5.46M | 0.01% |
394,669
+180,565
| +84% | +$2.2M |
|
960
PUT
ConocoPhillips
COP
$141B
| $5.43M | 0.01% |
+52,400
| New | +$5.38M |
|
961
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $5.43M | 0.01% |
72,300
-1,033,500
| -93% | -$77.1M |
|
|
BORR
962
Borr Drilling
BORR
$1.19B
| $5.43M | 0.01% |
720,566
-1,166,636
| -62% | -$8.36M |
|
963
Casella Waste Systems
CWST
$5.69B
| $5.42M | 0.01% |
+59,960
| New | +$5.35M |
|
964
iShares Biotechnology ETF
IBB
$9.71B
| $5.41M | 0.01% |
42,611
+24,324
| +133% | +$3.16M |
|
965
J&J Snack Foods
JJSF
$1.71B
| $5.4M | 0.01% |
34,103
-709
| -2% | -$110K |
|
966
PUT
Deere & Co
DE
$168B
| $5.39M | 0.01% |
+13,300
| New | +$5.09M |
|
|
RDUS
967
DELISTED
Radius Recycling
RDUS
| $5.38M | 0.01% |
179,533
+8,400
| +5% | +$253K |
|
968
Voyager Therapeutics
VYGR
$201M
| $5.37M | 0.01% |
469,277
+402,280
| +600% | +$4.16M |
|
|
FLDDW
969
CALL
Fold Holdings Warrant
FLDDW
$1.12M
| $5.37M | 0.01% |
518,181
-6,816
| -1% | -$627 |
|
|
DICE
970
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $5.37M | 0.01% |
+115,496
| New | +$3.99M |
|
971
PUT
Altria Group
MO
$114B
| $5.36M | 0.01% |
+118,300
| New | +$5.36M |
|
|
EBIX
972
DELISTED
Ebix Inc
EBIX
| $5.34M | 0.01% |
211,974
+86,094
| +68% | +$1.61M |
|
|
HAIAW
973
CALL
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
| $5.33M | 0.01% |
500,151
-948
| -0.2% | -$58 |
|
974
Immunocore
IMCR
$1.73B
| $5.32M | 0.01% |
88,804
+64,684
| +268% | +$3.69M |
|
975
Dutch Bros
BROS
$9.26B
| $5.29M | 0.01% |
+186,096
| New | +$5.52M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.